🔗 Share this article

Treasury head Rachel Reeves has revealed she is planning "targeted steps to tackle household expense pressures" in the upcoming financial statement.

In comments to media outlets, she stated that lowering inflation is a joint duty of both the administration and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Bill Interventions

Reports indicate the administration could take action to bring down utility costs, for instance by slashing the present 5% level of VAT charged on energy supplies.

Another possibility is to cut some of the regulatory levies presently added to bills.

Fiscal Constraints and Expert Expectations

The administration will obtain the next report from the official forecaster, the OBR, on the start of the week, which will reveal how much scope there is for these actions.

The expectation from the majority of experts is that the Chancellor will have to declare tax increases or budget cuts in order to meet her declared fiscal targets.

Earlier on the same day, estimates indicated there was a twenty-two billion pound gap for the Treasury chief to address, which is at the more modest range of expectations.

"It is a shared job between the central bank and the administration to bear down further on some of the causes of price increases," Reeves informed the BBC in Washington, at the annual meetings of the IMF and global financial institution.

Tax Pledges and Global Concerns

While a great deal of the focus has been on probable tax rises, the chancellor said the most recent figures from the OBR had not altered her vow to manifesto promises not to raise tax levels on earnings tax, VAT or social security contributions.

She blamed an "uncertain global environment" with rising geopolitical and commercial tensions for the Budget tax moves, probably to be focused on those "most able to pay."

International Economic Tensions

Commenting on concerns about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security always are paramount."

Recent statement by Chinese authorities to increase trade restrictions on rare earths and other resources that are essential for high-technology manufacturing led American leader the US President to suggest an additional 100% import tax on imports from China, raising the possibility of an full-scale trade war between the two largest economies.

The US Treasury Secretary called China's decision "economic coercion" and "a international production power grab."

Asked about considering the American proposal to join its conflict with the Asian nation, the Chancellor said she was "very concerned" by China's actions and called on the Chinese government "not to put up barriers and limit trade."

She said the decision was "damaging for the global economy and causes additional headwinds."

"It is my opinion there are fields where we must address Chinese policies, but there are also significant chances to export to China's economy, including financial services and other areas of the economy. We've got to achieve that equilibrium right."

The chancellor also confirmed she was working with G7 counterparts "regarding our own critical minerals plan, so that we are less reliant."

NHS Medicine Pricing and Investment

The Chancellor also acknowledged that the cost the National Health Service spends on pharmaceuticals could go up as a consequence of ongoing discussions with the Trump administration and its pharmaceutical firms, in return for lower tariffs and funding.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or canceling projects in the UK, with some attributing the low prices they are obtaining.

Last month, the government science advisor said the price the NHS spends on medicines would have to increase to prevent companies and drug research funding departing from the UK.

The Chancellor informed the BBC: "We have seen due to the cost structure, that drug testing, innovative medicines have not been offered in the UK in the way that they are in other continental states."

"The objective is to ensure that people receiving treatment from the NHS are can access the best essential medicines in the globe. And so we are examining these issues, and... looking to secure increased investment into Britain."